Nature of the Business - Additional Information (Detail) $ / shares in Units, $ in Thousands |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
May 04, 2026
USD ($)
$ / shares
shares
|
May 31, 2026
USD ($)
shares
|
Jun. 30, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Mar. 31, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
Patients
shares
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| Class of Stock [Line Items] | |||||||||
| Net proceeds from offering | $ 53,544 | $ 367 | |||||||
| Cash, cash equivalents and investments | $ 43,627 | $ 43,627 | |||||||
| Number of stock sold | shares | 255,000 | ||||||||
| Net loss | (6,375) | $ (5,838) | $ (6,822) | $ (5,501) | $ (12,213) | $ (12,323) | |||
| Accumulated deficit | $ (413,484) | $ (413,484) | $ (401,271) | ||||||
| Number of patients | Patients | 120 | ||||||||
| Underwritten Public Offering [Member] | |||||||||
| Class of Stock [Line Items] | |||||||||
| Net proceeds from offering | $ 53,099 | $ 53,099 | |||||||
| Gross proceeds from offering | 57,500 | 57,500 | |||||||
| Underwriting discounts, commissions, and offering expenses | $ 4,401 | $ 4,401 | |||||||
| Shares issued, price per share | $ / shares | $ 1 | ||||||||
| Offering Shares [Member] | Underwritten Public Offering [Member] | |||||||||
| Class of Stock [Line Items] | |||||||||
| Number of stock sold | shares | 50,000,000 | 57,500,000 | |||||||
| Shares issued, price per share | $ / shares | $ 1 | ||||||||
| X | ||||||||||
- Definition Gross proceeds from issuance of common stock. No definition available.
|
| X | ||||||||||
- Definition Number of maximum patient for trial. No definition available.
|
| X | ||||||||||
- Definition Underwriting discounts, commissions, and offering expenses. No definition available.
|
| X | ||||||||||
- Definition Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|